SCHEMBL8436628

SCHEMBL8436628

CCCSc1ccc(NS(=O)(=O)c2sc3ccc(Cl)cc3c2C)cc1

nearest known ligand 0.70

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 1/20 0.70
L3MBTL1 Q9Y468 1/20 0.70
CMA1 P23946 3/20 0.69
PFKFB3 Q16875 8/20 0.59
PFKFB4 Q16877 7/20 0.59
HTR6 P50406 7/20 0.54
HTR1A P08908 1/20 0.50
DRD2 P14416 1/20 0.50
HTR1D P28221 1/20 0.50
HTR1B P28222 1/20 0.50
HTR2A P28223 1/20 0.50
HTR2C P28335 1/20 0.50
HTR1E P28566 1/20 0.50
HTR1F P30939 1/20 0.50
HTR7 P34969 1/20 0.50
ADRA1B P35368 1/20 0.50
DRD3 P35462 1/20 0.50
HTR2B P41595 1/20 0.50
HTR4 Q13639 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12204617 0.85 NPSR1 (0.90) NPSR1L3MBTL1CMA1PFKFB3PFKFB4
SCHEMBL8255613 0.82 CMA1 (1.00) NPSR1L3MBTL1CMA1PFKFB3PFKFB4
SCHEMBL2910759 0.78 CMA1 (0.82) NPSR1L3MBTL1CMA1PFKFB3PFKFB4
SCHEMBL8259082 0.78 NPSR1 (0.76) NPSR1L3MBTL1CMA1PFKFB3PFKFB4
SCHEMBL5621758 0.78 PFKFB3 (0.80) NPSR1L3MBTL1CMA1PFKFB3PFKFB4
SCHEMBL8255568 0.78 CMA1 (0.80) NPSR1L3MBTL1CMA1PFKFB3PFKFB4
SCHEMBL8250288 0.77 NPSR1 (0.74) NPSR1L3MBTL1CMA1PFKFB3PFKFB4
SCHEMBL13212412 0.77 MAPT (0.41) NPSR1L3MBTL1CMA1PFKFB3PFKFB4
SCHEMBL8273991 0.76 CMA1 (0.70) NPSR1L3MBTL1CMA1PFKFB3PFKFB4
SCHEMBL15480585 0.76 CMA1 (0.77) NPSR1L3MBTL1CMA1PFKFB3PFKFB4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030229126-A1 N-substituted benzothiophenesulfonamide derivatives TOA EIYO LTD. 2003-12-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030229126-A1 N-substituted benzothiophenesulfonamide derivatives ECE1, ECE2, CMA1 NPSR1 88/4885L3MBTL1 3296/4885CMA1 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.